Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M McKenney

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
American Journal of Therapeutics|January 6, 2004
Optimizing LDL-C lowering with statinsJames M McKenney
Clinical Cardiology|April 24, 2003
Pharmacologic characteristics of statinsJames M McKenney
Pharmacotherapy|July 20, 2002
New cholesterol guidelines, new treatment challengesJames M McKenney
The American Journal of Cardiology|August 16, 2005
Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risksJames M McKenney
Journal of Clinical Lipidology|April 26, 2015
Understanding PCSK9 and anti-PCSK9 therapiesJames M McKenney
Pharmacotherapy|October 4, 2003
Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goalJames M McKenney
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 20, 2005
Efficacy and safety of rosuvastatin in treatment of dyslipidemiaJames M McKenney
The Annals of Pharmacotherapy|July 5, 2003
Potential nontraditional applications of statinsJames M McKenney
Journal of Clinical Lipidology|February 5, 2011
Effect of drugs on high-density lipoproteinJames M McKenney
Postgraduate Medicine|February 9, 2012
Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature reviewJames M McKenney
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
American Journal of Therapeutics|January 6, 2004
Optimizing LDL-C lowering with statinsJames M McKenney
Clinical Cardiology|April 24, 2003
Pharmacologic characteristics of statinsJames M McKenney
Pharmacotherapy|July 20, 2002
New cholesterol guidelines, new treatment challengesJames M McKenney
The American Journal of Cardiology|August 16, 2005
Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risksJames M McKenney
Journal of Clinical Lipidology|April 26, 2015
Understanding PCSK9 and anti-PCSK9 therapiesJames M McKenney
Pharmacotherapy|October 4, 2003
Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goalJames M McKenney
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 20, 2005
Efficacy and safety of rosuvastatin in treatment of dyslipidemiaJames M McKenney
The Annals of Pharmacotherapy|July 5, 2003
Potential nontraditional applications of statinsJames M McKenney
Journal of Clinical Lipidology|February 5, 2011
Effect of drugs on high-density lipoproteinJames M McKenney
Postgraduate Medicine|February 9, 2012
Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature reviewJames M McKenney
Pageof 7